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        Introduction 
  Prions are proteinaceous infectious agents that were fi  rst dis-
covered because of their role in the etiology of transmissible 
spongiform encephalopathies (TSEs), a set of fatal neurological 
disorders that include human Creutzfeldt-Jakob disease, ovine 
scrapie, and bovine spongiform encephalitis (  Prusiner et al., 
1998; DeArmond and Prusiner, 2003  ). TSEs arise from progres-
sive misfolding of the endogenous cellular prion protein (Prp 
[PrP 
C  ]) into disease-associated scrapie form (PrP 
Sc  ), which, in 
turn, disrupts normal cellular function and results in the forma-
tion of aggregates and amyloid-like plaques ( DeArmond, 2004 ). 
Although there has been a clear association between PrP 
Sc   with 
these disease states, the cellular function of PrP 
C   remains in-
completely understood (  Brown, 2001  ). PrP 
C   is expressed across 
the entire central nervous system and at particularly high levels 
in the hippocampus, striatum, and frontal cortex, with apparently 
wide subcellular distribution, including synaptic sites (  Sales 
et al., 1998; Fournier et al., 2000  ). A synaptic role of PrP 
C   is 
consistent with evidence from PrP-null mice showing defi  cits in 
spatial learning (  Criado et al., 2005  ), altered long-term potentiation 
(  Collinge et al., 1994  ;   Manson et al., 1995  ;   Curtis et al., 2003; 
Maglio et al., 2004, 2006  ), and increased excitability of hippo-
campal neurons (  Colling et al., 1996, 1997  ;   Collinge et al., 1994  ; 
  Mallucci et al., 2002  ). Several studies have also suggested 
that PrP 
C   may provide neuroprotection. For example, cultured 
hippocampal neurons obtained from PrP-null mice show an in-
creased apoptosis during oxidative stress (  Vassallo and Herms, 
2003  ). Mice lacking PrP 
C   show increased neuronal damage 
after ischemic stroke, whereas protection is evident upon the 
viral-based overexpression of PrP 
C   in rats (  McLennan et al., 
2004 ;  Shyu et al., 2005 ;  Spudich et al., 2005 ;  Weise et al., 2006 ). 
Finally, in several in vivo models of seizure activity, PrP-null 
mice showed increased mortality, likely as a consequence of 
hyperexcitability leading to excitotoxicity (  Walz et al., 1999  ). 
However, the cellular and molecular basis for these effects re-
mains unknown. 
  Neuronal excitability and excitotoxic neuronal cell death are 
also features associated with   N -methyl- d -aspartate  (NMDA)  re-
ceptor (NMDAR) activity ( Mody and MacDonald, 1995; Arundine 
and Tymianski, 2004  ). These receptors are comprised of two 
obligatory NR1 subunits that coassemble with two NR2 subunits 
into a tetrameric channel complex that is activated by glutamate 
and is permeable to both sodium and calcium ions. Four different 
NR2 subunit genes are expressed in the mammalian brain, and it 
is thought that neonatal synapses are mainly comprised of NR1/
NR2B receptors, whereas adult synapses preferentially express 
NR2A-containing receptors (  Cull-Candy and Leszkiewicz, 2004  ). 
  I
t is well established that misfolded forms of cellular 
prion protein (PrP [PrP 
C  ]) are crucial in the genesis and 
progression of transmissible spongiform encephalitis, 
whereas the function of native PrP 
C   remains incompletely 
understood. To determine the physiological role of PrP 
C  , 
we examine the neurophysiological properties of hippo-
campal neurons isolated from PrP-null mice. We show 
that PrP-null mouse neurons exhibit enhanced and drasti-
cally prolonged   N  -methyl-  D  -aspartate (NMDA)  –  evoked 
currents as a result of a functional upregulation of NMDA 
receptors (NMDARs) containing NR2D subunits. These 
  effects are phenocopied by RNA interference and are 
rescued upon the overexpression of exogenous PrP 
C  . The 
enhanced NMDAR activity results in an increase in neuronal 
excitability as well as enhanced glutamate excitotoxicity 
both in vitro and in vivo. Thus, native PrP 
C   mediates an 
important neuroprotective role by virtue of its ability to 
inhibit NR2D subunits.
  Prion protein attenuates excitotoxicity by inhibiting 
NMDA receptors 
    Houman     Khosravani  ,   
1       Yunfeng     Zhang  ,   
1       Shigeki     Tsutsui  ,   
2       Shahid     Hameed  ,   
1       Christophe     Altier  ,   
1       Jawed     Hamid  ,   
1     
  Lina     Chen  ,   
1       Michelle     Villemaire  ,   
2       Zenobia     Ali  ,   
2       Frank R.     Jirik  ,   
2     and   Gerald W.     Zamponi     
1     
   
1  Department of Physiology and Biophysics, Hotchkiss Brain Institute, and  
2  Department of Biochemistry and Molecular Biology, McCaig Institute for Bone and Joint Health, 
University of Calgary, Calgary T2N4N1, Canada     JCB • VOLUME 181 • NUMBER 3 • 2008  552
with previous fi  ndings under similar conditions (  Lledo et al., 
1996  ). In PrP-null slices, bath application of 50    M APV  attenu-
ated or abolished the occurrence of overriding population spikes, 
resulting in waveforms that were similar to recordings from WT 
slices (  Fig. 1 D  ). These data indicate that the enhanced excit-
ability observed in the PrP-null mice is in large part caused by 
the activity of NMDARs. In contrast, treatment with 100    M  of 
the    -aminobutyric  acid  (GABA A  ) receptor blocker picrotoxin 
did not reduce the number of population spikes in the PrP-null 
slices (reported for pulse 2: PrP 
+/+ ,  1.2   ±   0.2  spikes,   n   = 5; 
PrP 
   /    , 3.0   ±   0.44 spikes,   n   = 5; P = 0.006). 
  Removal of Mg 
2+   ions from the extracellular medium is 
known to induce a hyperexcitable state mainly as a result of the 
unblocking of NMDARs. To determine whether the absence of 
PrP 
C   protein exacerbates this effect, we compared the effect of 
removing extracellular Mg 
2+   ions on slices from WT and PrP-
null mice. Brain slice recordings were initially performed in 
normal aCSF to confi  rm the presence of stable fi  eld potentials. 
Slices were then exposed to an external solution containing zero 
Mg 
2+   (ZM-aCSF), and evoked synaptic responses were assessed 
using paired-pulse stimuli (  Fig. 1 E  ). Slices from both WT and 
PrP-null mice exhibited hyperexcitability within 5 min after 
exposure to ZM-aCSF and exhibited a marked increase in the 
number of population spikes, which was exacerbated in the PrP-
null mice (  Fig. 1 F  , left). Prolonged perfusion with ZM-aCSF is 
known to result in the appearance of epileptiform discharges 
that progress to seizurelike events in a subset of the slices. 
Under ZM conditions, the time to the appearance of the fi  rst dis-
charge was signifi  cantly shortened for PrP-null slices (  Fig. 1 F  , 
second graph). Furthermore, in slices that progressed to seizure-
like activity, the time to onset was signifi  cantly reduced, whereas 
the seizure duration was unaffected (  Fig. 1 F  , third and fourth 
graphs). Fourier transform analysis of the discharges revealed 
greater high frequency content in the discharges recorded in 
PrP-null slices compared with those obtained from WT animals, 
which is consistent with increased excitability in PrP-null slices 
(Fig. S1, available at http://www.jcb.org/cgi/content/full/jcb
.200711002/DC1). Collectively, these data are consistent with 
the results obtained in normal aCSF and indicate that augmenta-
tion of NMDARs by Mg 
2+   unblock exacerbates the effects of 
PrP 
C   on neuronal excitability. 
  Alterations in synaptic NMDAR-mediated 
currents in PrP-null mice 
  To directly measure the effect of PrP 
C   on synaptic NMDAR cur-
rents, we recorded miniature excitatory postsynaptic currents 
(mEPSCs) in mature (12  –  16 d in vitro [DIV]) primary hippo-
campal cultures bathed in ZM-aCSF supplemented with tetro-
dotoxin (TTX), picrotoxin, CNQX, and glycine. As shown in 
  Fig. 2  , mEPSCs recorded from PrP-null neurons showed events 
with signifi  cantly larger amplitudes than those observed in WT 
slices (  Fig. 2, A  –  D  ). Furthermore, NMDAR-mediated mEPSCs 
of PrP-null mouse neurons exhibited signifi  cantly longer decay 
times (  Fig. 2, B  –  D  ). In contrast, the frequency of events and 
rise time of the mEPSCs were unaffected by the absence of 
PrP 
C .  Signifi  cant changes were also observed in some param-
eters associated with AMPA/kainate-mediated mEPSCs and in 
NR2D receptor subunits are intriguing because their function-
ality has not been demonstrated in native synaptic currents, al-
though they appear to be present at the protein level (  Misra et al., 
2000  ;   Thompson et al., 2002  ). The NR2 subunit isoform is a key 
determinant of the functional properties of NMDARs, such as 
activation, desensitization, and deactivation kinetics, with NR2D 
subunits showing dramatically slower kinetic properties com-
pared with other NR2 (e.g., NR2B) subtypes when expressed 
heterologously (  Cull-Candy and Leszkiewicz, 2004  ). Recep-
tors containing different types of NR2 subunits share voltage-
dependent block by magnesium ions, coactivation by glycine, 
and inhibition by organic molecules such as MK-801 and amino-
phosphonovaleric acid (APV). In this context, it is interesting to 
note that the elevated susceptibility to neuronal damage observed 
in the PrP-null mice is diminished by the NMDAR blocker 
MK-801 (  Rangel et al., 2007  ), suggesting the possibility that PrP 
C   
may perhaps act by regulating NMDAR function. 
  In this study, we show that the absence of PrP 
C   gives  rise 
to the appearance of synaptic NMDAR currents with increased 
amplitude and slowed kinetics that resemble those of NR2D-
containing receptors, thus implying enhanced NMDAR activity 
in PrP-null neurons. Consistent with this fi  nding, in vitro and 
in vivo excitotoxicity assays reveal increased neuronal cell 
death in PrP-null cultures and animals upon transient exposure 
to NMDA. We demonstrate a novel functional role for PrP 
C   as  a 
modulator of synaptic NMDA currents and also attribute a neuro-
protective function to this molecule by way of its ability to sup-
press NMDAR activity. 
  Results 
  PrP-null mice exhibit greater 
basal excitability 
  To examine a possible role of PrP 
C   in neuronal excitability, we 
compared synaptic physiology in horizontal hippocampal slices 
obtained from adult (postnatal day [P] 30  –  45) wild-type (WT) 
and PrP-null (PrP 
   /    ) mice. Paired-pulse stimulation of Schaffer 
collaterals evoked paired synaptic responses in CA1 neurons 
when bathed in artifi  cial cerebrospinal fl  uid (aCSF). In WT 
slices, the synaptic responses observed were typical of hippo-
campal slice physiology, with waveforms exhibiting a robust 
presynaptic volley, a sharp downward defl  ecting population spike, 
and upward defl  ecting fi  eld excitatory postsynaptic potential 
(fEPSP) as well as robust paired-pulse facilitation (  Fig. 1 A  ). 
Paired evoked fi  eld potentials in slices from PrP-null mice ex-
hibited similar waveform properties and similar paired-pulse 
facilitation but showed an increase in the number of overriding 
polyspikes (  Fig. 1, A and B  ). This suggests that neurons in PrP-
null slices fi  re multiple action potentials in response to a single 
stimulus and indicates a basal increase in excitability. The mini-
mum stimulus threshold required to evoke a single population 
spike was reduced in PrP-null slices (  Fig. 1 C  , top), as was the 
stimulus intensity required to reach maximum response (  Fig. 1 C  , 
middle). In contrast, the magnitude of paired-pulse facilitation 
did not differ between WT and PrP-null mouse slices (  Fig. 1 C  , 
bottom). The increased apparent excitability of the null mouse 
neurons was abolished at room temperature, which is consistent 553 PRION PROTEIN MODULATES NMDA CURRENTS   •   Khosravani et al.
  Figure 1.       Field potentials recorded in the CA1 layer of hippocampal slices from WT and PrP-null mice.   (A) Paired pulses evoked by stimulation of the Schaffer 
collaterals in slices from P30  –  45 mice in normal artiﬁ  cial cerebrospinal ﬂ  uid (aCSF). (B) Quantiﬁ  cation of the number of population spikes in WT and 
PrP-null slices in aCSF. (C, top) Minimum stimulus intensity required to evoke a single population spike in WT and PrP-null slices. (middle) Stimulus intensity 
required to evoke maximum single population spike amplitude. (bottom) Extent of paired pulse facilitation in WT and PrP-null slices. (D, top) Field potentials 
recorded from PrP-null slices before and after the application of 50   μ  M APV as shown for P2. (bottom) Quantiﬁ  cation of the number of population spikes 
before and after APV application in PrP-null slices. (E) Evoked ﬁ  eld potentials recorded after 5 min of perfusion in zero-magnesium aCSF (ZM-aCSF). 
The gray arrows indicate successive population spikes, which are augmented in the PrP-null slices. (F, left) The number of population spikes overriding the fEPSP 
in slices exposed to ZM-aCSF. (second graph) Time to the observance of the ﬁ  rst seizurelike discharge in ZM-aCSF. (third graph) Time to the occurrence 
of the ﬁ  rst seizurelike event (SLE) upon perfusion with ZM-aCSF. (right) Duration of seizurelike events in WT and PrP-null slices. The black and gray arrow-
heads indicate the primary population spikes and the additional population spikes, respectively, overriding the fEPSP in each pulse (P1 and P2); these latter 
polyspikes were only observed in PrP-null mice. Data are represented as mean   ±   SEM (error bars) with statistical signiﬁ  cance denoted as *, P   <   0.05 and 
**, P   <   0.001. Numbers in parentheses indicate the number of slices.     JCB • VOLUME 181 • NUMBER 3 • 2008  554
 To conduct a more detailed analysis of NMDAR-mediated 
currents, NMDARs were activated by transient and focal appli-
cation of NMDA puffs to cultured hippocampal neurons held 
under voltage clamp. Currents were evoked using different puff 
durations from a glass patch pipette fi  lled with 100   μ  M NMDA 
in the presence of TTX, picrotoxin, CNQX, and glycine. As 
shown in   Fig. 3  , NMDA currents recorded from PrP-null mice 
GABA  A  -mediated miniature inhibitory postsynaptic current 
(mIPSCs), but these effects were smaller in magnitude than those 
observed with NMDAR-mediated events (Fig. S2, available at 
http://www.jcb.org/cgi/content/full/jcb.200711002/DC1). Over-
all, these data are consistent with the increased excitability ob-
served in PrP slices and, furthermore, provide direct evidence of 
PrP 
C  -mediated modulation of synaptic NMDARs. 
  Figure 2.       Analysis of miniature synaptic NMDAR currents in cultured hippocampal neurons from WT and PrP-null mice.   (A) Representative examples of 
raw mEPSCs recorded in mature (12  –  16 DIV) WT and PrP-null hippocampal neurons in culture. In PrP-null neurons, NMDA-mediated mEPSCs were ob-
served to be larger and showed prolonged decay times. (B) Event histograms for mEPSC amplitude (top) and decay time (bottom). Note that mEPSCs in 
PrP-null neurons exhibit a shift toward larger amplitude events and increased decay time constants. (C) Cumulative probability plots for mEPSC amplitude 
and decay times showing a shift in each summed distribution toward larger events with longer decay times (P   <   0.05; Kolmogorov-Smirnov test). (D) Mean 
values for mEPSC waveform parameters showing increased EPSC amplitudes and prolonged decay times. Here, decay time refers to the time required for 
an e-fold reduction in peak current amplitude. Data are represented as mean   ±   SEM (error bars), with statistical signiﬁ  cance denoted as *, P   <   0.05 and 
**, P   <   0.001. Numbers in parentheses indicate the number of cells.     555 PRION PROTEIN MODULATES NMDA CURRENTS   •   Khosravani et al.
  Figure 3.       Kinetic analysis of evoked NMDAR-mediated currents in cultured hippocampal neurons from WT and PrP-null mice.   (A) Representative NMDAR-
mediated currents in response to 100-    M transient NMDA puff application at 50- and 100-ms durations for WT (black) and PrP-null (red) neurons. Note 
the prolonged decay kinetics in the PrP-null neurons. The records were arbitrarily scaled to overlap at peak. (B) Time to 50% decay (i.e., the time required 
for decay to half-maximum peak current amplitude) for WT and PrP-null neurons. (C) Current amplitudes evoked by 50- and 100-ms puffs of NMDA for WT 
and Prp-null neurons. (D, left) Cultured WT mouse hippocampal neurons cotransfected with YFP and siRNA against PrP 
C   and permeabilized and stained 
with a PrP 
C   antibody. Note that the YFP-positive (i.e., siRNA transfected) cell is negative for PrP 
C  , whereas a YFP-negative cell in the same dish shows robust 
PrP expression. The arrowheads indicate the location of the soma. (E) Time to 50% decay for WT neurons transfected with siRNA against PrP for an NMDA 
puff duration of 100 ms. Data were compared with culture-matched neurons transfected with YFP alone or nearby untransfected (UT) cells within the same 
siRNA-transfected culture. (F) Time to 50% decay for PrP-null neurons transfected with PrP cDNA plus a YFP marker. Currents were evoked with a 100-ms 
puff of NMDA. Data were compared with culture-matched YFP alone or untransfected cells. Data are represented as mean   ±   SEM (error bars), with statis-
tical signiﬁ  cance denoted as *, P   <   0.05 and **, P   <   0.001. Numbers in parentheses indicate the number of cells. Bar, 30   μ  m.     JCB • VOLUME 181 • NUMBER 3 • 2008  556
  Figure 4.       Analysis of the NMDAR NR2D subunit distribution.   (A) Western blot analysis of the NR2D subunit protein expression in neonatal and adult 
hippocampal tissue obtained from the WT and PrP-null mouse.     -Actin expression was used as a loading control. (B) NMDAR subunit surface expression 
as visualized by immunolabel reactivity with an antibody targeted against an extracellular (N terminus) epitope of NR2D. A punctate pattern of receptor 
distribution is visualized along dendritic processes. The depth of ﬁ  eld is     1   μ  m. (C) Surface expression of NR2D relative to total cellular NR2D protein 557 PRION PROTEIN MODULATES NMDA CURRENTS   •   Khosravani et al.
  Expression of NR2D subunits in WT and 
PrP-null mice 
  The prolonged current decay kinetics observed in evoked whole 
cell NMDA currents in PrP-null mice are reminiscent of the 
slow current waveforms observed upon transient expression 
of NR1/NR2D receptors in tsA-201 cells (  Vicini et al., 1998  ). 
This suggests the possibility of a functional upregulation of 
NR2D-containing receptors in PrP-null mouse neurons. To de-
termine whether the absence of PrP 
C   triggered the expression of 
NR2 subunits, NRD2 protein expression levels and subcellular 
distribution were examined in hippocampal neurons of WT and 
PrP-null mice. As shown in   Fig. 4 A  , NR2D protein could be 
detected in hippocampal tissue of both WT and PrP-null mice, 
irrespective of the age of the animals. Furthermore, RT-PCR 
analysis indicated that mRNA for all NMDAR subtypes, includ-
ing NR2D, is present in both WT and PrP-null mouse neurons 
and at comparable levels (Fig. S4, available at http://www.jcb
.org/cgi/content/full/jcb.200711002/DC1). The distributions of 
NR2D receptors in WT and PrP-null mouse neurons were as-
sayed by immunostaining of neurons with an NR2D antibody. 
As shown in   Fig. 4 B  , similar distributions of NR2D subunits were 
observed in both WT and PrP-null mice, with receptors being 
expressed both on the soma as well as on dendritic processes. 
Quantitative analysis of the NR2D staining patterns showed no 
differences in the number of synaptic puncta (PrP 
+/+   and  PrP 
   /   , 
46   ±   13 and 43   ±   11 synaptic clusters/100     m of dendrite, 
respectively; P   >   0.9). Furthermore, the distribution of synapsin I 
and NR1 subunits, as putative markers of pre- and postsynaptic 
contacts, was used to rule out the gross synaptic morphological 
alterations in knockout mice (Fig. S5). 
  The NR2D antibody used in our study recognizes an ex-
tracellular epitope on the NR2D subunit. This allowed us to 
use luminometry to quantify the fraction of NR2D subunits 
expressed at the cell surface relative to total NR2D expression 
by comparing immunoreactivity in permeabilized and non-
permeabilized cells. As shown in   Fig. 4 C  , in both WT and 
PrP-null cultures, the NR2D surface expression level amounted 
to approximately 80% of total NR2D protein. Collectively, 
these data indicate that hippocampal neurons in both WT and 
PrP-null mice express similar levels of NR2D surface protein, 
with no apparent differences in subcellular distributions of NR2D 
subunits. These data suggest that PrP 
C   does not act by increas  -
ing the amount of NR2D protein at the cell surface. To deter    -
mine whether NR2D receptor subunits were responsible for the 
slow current kinetics observed in PrP-null mouse neurons, we 
transfected knockout neurons with either YFP or YFP plus a 
set of siRNA constructs directed against NR2D and examined 
current amplitude evoked by 50- or 100-ms puffs of NMDA. 
exhibited signifi  cantly slowed deactivation kinetics compared 
with those observed in WT neurons irrespective of puff duration 
(i.e., 50 or 100 ms). This effect was quantifi  ed by measuring 
the time at which current had decayed by 50% (termed time to 
50% decay;   Fig. 3 B  ), as the kinetics observed in the PrP-null 
neurons were too slow to be amenable to exponential fi  tting. 
Indeed, some PrP-null neurons yielded NMDA currents that 
required   >  10 s to decay, which was never observed in WT neurons. 
In addition, 50-ms NMDA puffs activated larger currents in the 
knockout cultures compared with WT cultures, whereas similar 
current amplitudes were evoked in both cultures when NMDA 
was puffed for 100 ms ( Fig. 3 C ). We also applied longer NMDA 
puffs of 500-ms duration that resulted in a drastic slowing of 
decay kinetics in both cultures, which was nonetheless still sig-
nifi  cantly augmented in the null mouse neurons (unpublished 
data). However, the enhanced slowing at higher NMDA concen-
trations likely refl  ects the incomplete clearance of NMDA after 
the puff rather than pure receptor deactivation. Thus, further 
analysis was restricted to shorter NMDA puffs. Application of 
3     M of the NR2B selective inhibitor Ifenprodil resulted in 
only a 19   ±   9% (  n   = 5) inhibition of NMDAR current amplitude. 
In contrast, the same concentration of Ifenprodil mediated a 59   ±   
4% (  n   = 8) inhibition of current amplitude in WT cultures. This 
observation implies that NR2B-mediated currents comprise a 
larger proportion of active NMDAR channels in WT neurons. 
Collectively, these data are consistent with an NMDAR hyper-
function upon knockout of native PrP 
C  , which is not caused by 
an augmentation of NR2B-containing receptors. Similar exper-
iments in which GABA  A   or AMPA/kainate receptors were acti-
vated with agonist puffs did not reveal any differences between 
WT and PrP-null neurons (Fig. S3, available at http://www.jcb
.org/cgi/content/full/jcb.200711002/DC1). 
  To determine whether the slowed NMDA current kinetics 
in PrP-null mouse neurons were mediated by the long-term ab-
sence of PrP 
C   during in utero development, WT cultures were 
transfected with three different siRNA constructs directed 
against the PrP mRNA sequence. PrP expression was observed 
to signifi  cantly decrease in siRNA-transfected neurons (  Fig. 3 D  ). 
As shown in   Fig. 3 E  , siRNA knockdown of PrP 
C   in culture 
phenocopied the PrP-null mice in that a two-fold increase in 
NMDAR-mediated current decay time was observed relative to 
untransfected neurons. Conversely, the overexpression of   Prnp  
cDNA in neurons obtained from PrP-null mice rescued the WT 
phenotype (  Fig. 3 F  ), again hinting at a specifi  c regulation of 
NMDARs by PrP 
C   rather than broad developmental effects 
  associated with deletion of the   Prnp   gene. Overall, our data sug-
gest that PrP 
C   is a negative regulator of NMDAR function in 
hippocampal neurons. 
content as quantiﬁ  ed using an ELISA assay in permeabilized (P) and nonpermeabilized (NP) cells. The number of neuronal culture samples is indicated 
in parentheses. Error bars represent SEM. (D) Coimmunoprecipitation of PrP 
C   and NR2D using both permutations of tag and probe showing that PrP and 
NR2D are in a complex. In the top panel, the blot was probed with a PrP antibody, and in the bottom panel, membrane was probed with NR2D antibody. 
The lane labeled control reﬂ  ects beads without antibody. The experiment is a representative example of four different repetitions for both neonatal and adult 
mouse hippocampal tissue. (E) Western blot demonstrating the lack of coimmunoprecipitation between NR2B and PrP 
C  , whereas NR2B can be detected in 
brain homogenate (input). (F) Costaining of WT mouse hippocampal neurons for PrP 
C   (red) and NR2D (blue). The cells were not permeabilized, thus allow-
ing for the selective staining of cell surface protein. The white line in the top left panel indicates the position of the linescan shown in the bottom left panel. 
The rectangle in the merged image (top right) corresponds to the magniﬁ  ed images shown at the bottom right. The arrowheads highlight examples of clear 
colocalization between NR2D and PrP 
C  . Bars: (B, top left) 7.5     m; (B, top right and F, top) 10     m; (B, bottom) 1     m; (F, bottom) 2     m.     
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PrP-null mice exhibit an enhanced susceptibility to NMDAR-
mediated excitotoxicity, which is consistent with the enhanced 
NMDAR activity observed in these animals. 
  Discussion 
  Since its discovery as an endogenous protein, the physiological 
functions of PrP have remained incompletely defi  ned. The par-
ticularly high level of expression of PrP 
C   in nervous tissue has 
pointed to a functional role in neuronal and/or glial elements. 
PrP 
C   has been localized to synaptic contacts, suggesting a possi-
ble role in synaptic physiology. However, its precise localization 
within pre- and/or postsynaptic membranes requires further in-
vestigation (  Herms et al., 1999; Fournier et al., 2000  ). A possible 
role of PrP 
C   in synaptic function is supported by the notion that 
PrP-null mice display impaired spatial learning and altered ex-
citatory and inhibitory neurotransmission (  Collinge et al., 1994  ; 
  Criado et al., 2005  ). Our fi  ndings showing that deletion of the 
PrP gene in mice results in altered synaptic NMDAR function is 
consistent with an important role of PrP in synaptic function. 
  The synaptic properties of PrP-null mouse neurons have 
been subject to previous investigation by other laboratories. 
  Collinge et al. (1994)   reported the presence of additional popu-
lation spikes in extracellular CA1 fi  eld recordings of PrP-null 
mice, which agrees with our observations. However,   Collinge 
et al. (1994)   attributed this effect partly to impaired GABAer-
gic signaling as refl  ected in reduced IPSP amplitudes and in-
creased rise and decay times. Although the rise and decay times 
of GABAergic mIPSCs were slightly increased in null mouse 
cultures, we did not observe any changes in agonist-evoked 
GABA  A   currents, and IPSC amplitude was unaffected in our 
hands. Instead, the enhanced number of population spikes was 
greatly reduced or abolished upon application of the NMDAR 
antagonist APV, indicating that the increase in excitability was 
mainly caused by an NMDAR-mediated action. In contrast, 
  Lledo et al. (1996)   failed to observe any alterations of either 
excitatory or inhibitory synaptic transmission. Similarly,  Carleton 
et al. (2001)   failed to observe multiple population spikes in the 
PrP-null mice. However, in both of these studies, slice experi-
ments were conducted at room temperature rather than at 32  °  C, 
a condition under which we noted a similar loss of excitability 
of the null mouse cultures. In recordings conducted at 28  °  C, 
  Maglio et al. (2004  ,   2006  ) did not report gross alterations in 
the shape of fi  eld potentials; however, no quantifi  cation of 
numbers of population spikes was conducted. In Purkinje neu-
rons, no difference between WT and PrP-null mice was re-
ported for GABAergic and glutamatergic synaptic currents 
(  Herms et al., 1995  ). These authors conducted their recordings 
in the presence of extracellular Mg 
2+ , which eliminates NMDAR-
mediated synaptic currents and thus isolates the AMPA receptor –
 mediated component. Thus, their data showing normal synaptic 
AMPA currents are in agreement with our fi  ndings. Our obser-
vation that paired-pulse facilitation, as assessed in the CA1 
layer of the hippocampus, was not different between WT and 
PrP-null mice is consistent with previous studies (  Carleton et al., 
2001  ;   Curtis et al., 2003  ). Finally, we note that   Criado et al. 
(2005)   recorded  fi  eld responses from hippocampal neurons in 
Elimination of NR2D subunits via siRNA treatment resulted in 
a drastic reduction in NMDA current amplitude compared with 
neurons transfected with only YFP (PrP 
   /    , 299   ±   113 pA, 
  n   = 18; PrP 
   /     with NR2D RNAi, 40   ±   9 pA,   n   = 25; for a 100-ms 
puff of NMDA). Furthermore, after NR2D knockdown, the ki-
netics of the remaining NMDA currents were drastically accel-
erated (PrP 
   /    , 0.6   ±   0.2 s,   n   = 18; PrP 
   /     with NR2D RNAi, 
0.21   ±   0.02 s,   n   = 25). Collectively, these data indicate that the 
slow NMDA currents observed in PrP-null mouse neurons are 
largely caused by NMDARs containing the NR2D subunit and 
that these receptors, although present, appear to be functionally 
silenced by PrP 
C . 
  Given these fi  ndings, it is possible that there is a direct 
regulation of NR2D-containing NMDARs by PrP 
C .  To  examine 
whether there is a close association of NR2D subunits and PrP 
C , 
we performed coimmunoprecipitations from WT mouse hippo-
campal homogenate. As shown in   Fig. 4 D  , PrP 
C   and  NR2D 
subunits effectively coimmunoprecipitated, indicating that these 
proteins form a signaling complex. In contrast, NR2B subunits 
did not immunoprecipitate with PrP 
C   ( Fig.  4  E ).  Double  label-
ing of WT mouse hippocampal neurons with NR2D and PrP 
C  
antibodies confi  rmed colocalization between these two proteins 
(  Fig. 4 F  ). Overall, our data indicate an association of PrP 
C   with 
NR2D subunits, which may serve to silence the activities of 
NR2D-containing NMDARs. 
  Elevated NMDAR-mediated cell death in 
PrP-null mice 
  It is well established that NMDARs are important mediators of 
excitotoxic cell death. In view of the increased NMDAR function 
in PrP-null mouse neurons, these neurons might show increased 
susceptibility to glutamate toxicity. To examine this possibility, 
we transiently (i.e., for 20 min) exposed mature hippocampal 
cultures to varying concentrations of NMDA, allowed neurons 
to recover for 24 h, and assayed cell death via TUNEL and trypan 
blue staining (  Fig. 5, A and B  ). Under control conditions, the 
percentage of TUNEL-positive cells was similar for WT and PrP-
null mouse cultures, whereas a signifi  cantly greater percentage 
of TUNEL-positive cells was observed for PrP-null neurons at a 
range of different NMDA concentrations (  Fig. 5 B  ). Similarly, 
transient exposure to NMDA induced a greater percentage of 
trypan blue  –  positive neurons in cultures obtained from PrP-null 
mice (  Fig. 5 B  ). The effect of NMDA on the fraction of TUNEL-
positive cells was signifi  cantly reduced upon block of NMDARs 
by the application of APV, thus confi  rming that NMDA medi-
ated its action via the appropriate receptor. 
  To determine whether PrP-null mice would exhibit a 
greater susceptibility to excitotoxic cell death in vivo, NMDA 
was administered by transient focal injection into the hippo-
campus, and lesion size was quantifi  ed by Fluoro-Jade staining. 
In both WT and PrP-null mice, the lesion size in response to in-
jection of the vehicle was restricted to the damage caused by the 
insertion of the delivery cannula. Injection of NMDA (10 nmol) 
resulted in an increase in lesion size that was signifi  cantly 
greater in the PrP-null mice compared with WT animals (  Fig. 6, 
A and B  ). This observation is in agreement with our fi  ndings in 
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  Figure 5.       NMDAR-mediated excitotoxic cell death in PrP-null neurons.   (A) Light microscope images of neuronal cultures after 20 min of exposure to 0.3, 0.6, 
and 1.0 mM NMDA followed by 24-h recovery. Cells were stained with trypan blue (dark blue) and TUNEL (brown); methyl green was used as the counter-
stain. (B) Mean cell counts for trypan blue  –   and TUNEL-stained cells in WT and PrP-null cultures. (C) Light microscope images showing TUNEL-stained neurons 
from PrP-null mice in the presence of NMDA and NMDA + APV. (D) Percentage of TUNEL-positive neurons from PrP-null mice in response to NMDA and 
NMDA + APV. The drug concentrations were 1 mM NMDA and 100   μ  M APV. Data are represented as mean   ±   SEM (error bars), with statistical signiﬁ  cance 
denoted as *, P   <   0.05 and **, P   <   0.001. Data were obtained from four culture rounds, and six random ﬁ  elds were imaged per condition. Bar, 100   μ  m.     JCB • VOLUME 181 • NUMBER 3 • 2008  560
  Figure 6.       Increased excitotoxic cell death and lesion 
size in the hippocampus of PrP-null mice in response 
to in vivo transient NMDA exposure.   (A) Fluoro-Jade 
labeling of neuronal bodies and processes in hippo-
campal sections in response to injection of vehicle 
(left) or NMDA (10-nmol equivalent; right). (B) Quanti-
ﬁ  cation of lesion size relative to the hippocampus over 
a series of three to six sections per animal (  n   = 5 per 
experimental group). Data are represented as mean   ±   
SEM (error bars), with statistical signiﬁ  cance denoted 
as **, P   <   0.001. Bar, 200   μ  m.     
vivo and found that stimulus threshold and population spike 
height were similar in WT and knockout animals. However, 
these experiments were conducted on the   Edinburgh   PrP 
knockout mouse strain rather than the   Zurich1   mice used in our 
study, thus precluding fi  rm comparisons. Indeed, there are sev-
eral knockout mouse lines that lack   PrP 
C     ( Sakudo  et  al.,  2006 ; 
  Steele et al., 2007  ), and these may account for some of the ob-
served differences. 
  Our data show a robust enhancement of synaptic NMDA 
currents in PrP-null mice, which could be mimicked upon siRNA 
depletion of PrP 
C   and rescued by overexpression of exogenous 
  Prnp   cDNA. The enhancement and broadening of NMDAR-
mediated mEPSCs could, in principle, be the result of either pre- or 
postsynaptic effects such as increased quantal content, impaired 
glutamate reuptake, or enhancement of NMDAR function in the 
postsynaptic membrane. The unaltered degree of paired-pulse 
facilitation fi  ts with a postsynaptic mechanism of action. The 
broadening and increased amplitude of the mEPSCs is consistent 
with our evoked whole cell recordings showing an apparent en-
hancement of NMDA affi  nity and prolonged current deactivation 
kinetics in response to direct activation of the receptors. Thus, 
although we cannot rule out the possibility of a contribution from 
presynaptic effects, our data are most consistent with a post-
synaptic action of PrP 
C   by virtue of altered NMDAR function. 
  Previous in situ hybridization experiments have suggested 
that NR2A and NR2B but not NR1 mRNA may be upregulated 
in both young and adult PrP-null mice (  Maglio et al., 2004, 
2006  ), which is not supported by our semiquantitative PCR ex-
periments. Furthermore, several lines of evidence suggest that 
the enhanced NMDA currents in cultured neurons are not caused 
by an enhanced expression of NR2A and/or NR2B subunits. 
NR2A subunit  –  containing receptors (which comprise the bulk 
of the synaptic NMDARs in adult neurons) typically exhibit 
the most rapid decay kinetics among all NMDAR isoforms, 
whereas NR2B receptors deactivate more slowly (  Cull-Candy 
and Leszkiewicz, 2004  ). The observation that the NR2B antag-
onist Ifenprodil did not block the slow NMDA currents in PrP-
null mouse neurons suggests that the observed kinetic slowing 
is not caused by a switch from NR2A- to NR2B-containing re-
ceptors upon deletion of the PrP gene. Moreover, the current 
decay kinetics observed in the PrP-null neurons were much 
slower than those expected for NR2B-containing receptors and 
instead resembled those observed with transiently expressed re-
ceptors containing NR2D subunits (  Vicini et al., 1998  ). Consis-
tent with such a mechanism, siRNA depletion of NR2D subunits 
greatly diminished (and accelerated) the NMDA currents seen 
in PrP-null mouse cultures. WT and PrP-null mouse neurons 
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of PrP are detectable in surviving neurons localized to the peri-
infarct region (  Weise et al., 2004; Mitsios et al., 2007  ). This 
raises the intriguing possibility that enhanced PrP expression 
may be a compensatory mechanism to protect from NMDAR-
mediated cell damage during ischemic insults. 
  It is unclear how NMDAR-mediated cell death contrib-
utes to the etiology of prion disease. During the development of 
prion disease, endogenous PrP 
C   is progressively misfolded, re-
sulting in the formation of PrP 
Sc   aggregates and, as has recently 
been shown, in a signifi  cant knockdown of endogenous PrP 
C  
levels (  Griffi  n et al., 2007  ). This type of depletion of normal 
PrP 
C   levels may well mimic some aspects of the phenotype of 
PrP knockout (such as enhanced NMDAR activity). This alone 
cannot account for the disease progression because PrP-null 
mice are intrinsically resistant to the infectious form of PrP, and 
deletion of the   Prnp   gene rescues animals from disease progres-
sion (  Mallucci et al., 2007  ). Furthermore, although PrP-null 
mice were recently shown to exhibit some evidence of sponta-
neous neurodegeneration with age (  Nazor et al., 2007  ), they do 
not develop classical and fatal TSE, indicating that normal 
endogenous glutamate levels are insuffi  cient to trigger massive 
NMDAR-mediated toxicity in the absence of PrP. However, it is 
likely that the accumulation of PrP 
Sc   aggregates on neurons and 
glial cells (  Rezaie and Lantos, 2001  ) results in enhanced gluta-
mate levels in the diseased brain as caused by cell damage. 
In conjunction with enhanced NMDAR function caused by 
lower normal PrP 
C   levels, this could ultimately contribute to the 
excitotoxic cell death of neurons observed in TSEs. Indeed, this 
would fi  t with previous studies showing that scrapie-infected 
neuronal cultures and cultures treated with infections prion 
fragments show increased neuronal survival upon NMDAR 
blockade (  Muller et al., 1993  ;   Brown et al., 1997  ;   Sassoon et al., 
2004  ). However, such putative linkages need to be further ex-
plored experimentally. 
  In summary, our results identify PrP 
C   as a regulator of 
NMDAR function and demonstrate that PrP 
C   exerts a neuro-
protective role by inhibiting aspects of NMDAR activity linked 
to excitotoxic cell death. The regulation of synaptic NMDARs 
implicates PrP 
C   as a modulator of synaptic function and, conse-
quently, neuronal excitability. 
  Materials and methods 
  PrP-null mice 
  Mice with a targeted disruption of the prion gene (PrP) of the Z  ü  rich 1 strain 
(  Bueler et al., 1992  ) and their controls (both of a mixed 129 and FVB back-
ground) were obtained from the European Mouse Mutant Archive (EM:0158; 
European Mouse Mutant Archive Rome) and interbred to generate PrP 
    /       
(PrP null) and PrP 
+/+   (WT) littermates used in the experiments. Genotyping 
was performed by gel electrophoresis of PCR products obtained from geno-
mic DNA that was isolated from tail samples. Primers and PCR parameters 
were similar to those used previously (  Bueler et al., 1992  ). Comparisons 
were made between electrophysiological recordings obtained from offspring 
pups (WT and PrP 
    /      littermates) from the original breeding pairs or from 
offspring obtained from PrP 
+/+     ×   PrP 
+/+   or PrP 
    /        ×   PrP 
    /      crosses; in all 
instances, the results were indistinguishable (  n     >   20 in each case), indicating 
that the variability in genetic background had no detectable effect on the 
observed phenotype. The experimentalists were blinded to the genotype of 
the mice for greater than half of the electrophysiological experiments (  n     >   30 
for each genotype) and became unblinded when no differences were identi-
ﬁ  ed that suggested an experimenter-dependent segregation of results. 
of NR2D protein expressed at the cell surface. Because isolated 
NR2 subunits do not traffi  c to the plasma membrane unless they 
are in a complex with an NR1 subunit (  Dunah et al., 1998; Cull-
Candy and Leszkiewicz, 2004  ), the NR2D receptors expressed 
in the plasma membrane of WT mouse neurons are likely part 
of fully assembled NMDAR complexes. This implies that the 
NR2D-containing NMDARs in WT neurons are electrically silent. 
Thus, the presence of PrP 
C   in these neurons appears to impair 
NR2D receptor function rather than primarily regulating recep-
tor traffi  cking. It is important to note that NR2D-like synaptic 
miniature currents have, to our knowledge, never been demon-
strated in WT hippocampal neurons, which is consistent with 
tonic inhibition of these receptors by PrP 
C . 
 PrP 
C   and NR2D subunits could be coimmunoprecipitated 
from hippocampal homogenate, indicating that NR2D-containing 
receptors form a protein complex with PrP 
C  , but it is unclear 
exactly how PrP 
C   functionally inhibits NMDAR activity. The fact 
that functional NR1/NR2D currents can be recorded in tsA-
201 cells even though these cells express endogenous PrP 
C  
might argue against a direct silencing of NR2D-containing 
receptors. However, exogenously expressed NMDAR subunits 
may outnumber endogenous PrP 
C   levels in these cells, thus 
leaving the possibility of a direct regulation of NR2D-containing 
receptors by PrP 
C  . This could occur by mechanisms such as 
a PrP 
C  -mediated stabilization of closed states or interference 
with glutamate or coagonist binding. Alternatively, NMDARs 
are known to be potently regulated by several protein kinases 
and phosphatases (  Wang and Salter, 1994; Dalva et al., 2007  ), 
and it is thus possible that PrP 
C   activates second messenger 
pathways that inhibit the function of NR2D-containing recep-
tors. Future experimentation will be required to dissect the 
mechanisms by which PrP regulates NMDAR activity. How-
ever, irrespective of the molecular mechanisms underlying the 
observed effects, our data support a major role of PrP 
C   in regu-
lating NMDAR function. 
  The notion of enhanced NMDAR activity in PrP-null 
mouse neurons is consistent with the enhanced NMDA toxicity 
observed in our in vitro and in vivo studies and indicates that PrP 
C   
provides a degree of neuroprotection from glutamate toxicity. 
This is supported by the recent fi  ndings of   Rangel et al. (2007)  , 
who reported that kainic acid application mediates increased 
cell death in organotypic brain slices cultured from PrP-null 
mice. Intriguingly, this effect was attenuated by the NMDAR 
inhibitor MK-801, suggesting that activation of kainate recep-
tors in this model may cause its toxic effects indirectly via 
NMDARs, perhaps by depolarization-induced Mg 
2+   unblock. 
Our fi  ndings showing increased NMDAR activity in null mice 
would be consistent with such a mechanism. Similarly, the 
  enhanced cell death observed in pharmacologically induced 
seizure models seen with PrP-null mice may be related to NMDAR 
hyperfunction. The role of glutamate-dependent neuronal death 
involving NMDARs is also a key feature of ischemic stroke 
(  Arundine and Tymianski, 2004  ). It this context, it is interesting 
to note that a recent study has demonstrated an upregulation 
of endogenous PrP in response to acute ischemic stroke in rats 
and also reported elevated PrP plasma levels in human stroke 
patients (  Mitsios et al., 2007  ). Furthermore, increased levels JCB • VOLUME 181 • NUMBER 3 • 2008  562
with pulse delivery under computer control. The minimum stimulus intensity 
was obtained by noting the stimulus intensity required to evoke the ﬁ  rst 
instance of a population spike using the ﬁ   rst pulse. Maximum stimulus 
threshold was determined at the stimulus intensity at which the amplitude of 
the population spike reached a plateau. Stimulus intensity was ﬁ  xed  at 
80% of maximum for other experiments, including zero-magnesium and 
pharmacology experiments involving APV. Extracellular potentials were re-
corded using a patch pipette ﬁ  lled with 150 mM NaCl. 
  Successful whole cell voltage and current clamp recordings were 
obtained from neuronal cultures between DIV 10 and 16. Miniature post-
synaptic currents were recorded in voltage-clamp mode from putative pyra-
midal neurons using either Axopatch 200B or Multiclamp 700B ampliﬁ  ers 
(MDS Analytical Technologies). For recording excitatory (i.e., AMPA/kainate 
and NMDA) mEPSCs, a holding potential of     60 mV was used to ob-
tain maximal responses. Inhibitory GABA  A   mIPSCs were recorded at a 
holding potential of 10 mV. Current clamp recordings were made in I-Fast 
mode with cells hyperpolarized to     70 mV. The intracellular solution for 
voltage-clamp experiments contained the following: 100 mM Cs-gluconate, 
1.7 mM CsCl, 10 mM EGTA, 5 mM MgCl  2  , and 40 mM Hepes adjusted 
to pH 7.3 with CsOH. The intracellular solution for current clamp experi-
ments contained the following: 100 mM K-gluconate, 1.7 mM KCl, 0.6 mM 
EGTA, 5 mM MgCl  2  , and 40 mM Hepes adjusted to pH 7.25 with KOH. 
Both internal solutions were supplemented with 2 mM Tris-ATP, 0.5 mM 
Na-GTP, and 5 mM phosphocreatine. 
  The standard extracellular bath solution was aCSF. The following 
agonists and antagonists were used for isolating speciﬁ  c synaptic currents: 
for recording AMPA/kainate EPSCs, we used 0.5   μ  M TTX (Alomone) and 
100   μ  M picrotoxin (Sigma-Aldrich) in standard 2 mM Mg 
2+  . For isolating 
NMDA EPSCs or whole cell currents, we used 15   μ  M CNQX (6-cyano-7-
nitroquinoxaline-2,3-dione disodium salt) and 20   μ  M glycine, which were 
added to a zero-magnesium aCSF in the presence of TTX and picrotoxin. 
For NMDA puff experiments requiring selective block of NR2B-containing 
receptors, we included 3     M Ifenprodil in the extracellular and pipette so-
lutions. Miniature GABAergic IPSCs were recorded in aCSF with 2 mM 
Mg 
2+   in the presence of CNQX and TTX. Current clamp recordings were 
performed in the absence of any drugs. All experiments were performed at 
32   ±   1  °  C with perfusion rates near 1  –  2 ml/min. Patch electrodes had tip 
resistances ranging from 5 to 8 M  Ω   when ﬁ  lled with internal solution; se-
ries resistance was compensated by 80%. For current clamp recordings, 
only neurons with input resistances   <  250 M  Ω   and resting membrane po-
tentials more hyperpolarized than     50 mV were considered for analysis. 
Electrophysiological data were acquired in pClamp 9.2 using a DigiData 
1322A (MDS Analytical Technologies). For voltage-clamp recording, data 
were ﬁ  ltered at 2 kHz with an eight-pole low-pass ﬁ  lter and sampled at 
10 kHz; current clamp recordings were ﬁ  ltered at 10 kHz and sampled at 
50 kHz. Recordings of spontaneous excitatory miniatures were analyzed 
using MiniAnalysis (Synaptosoft, Inc). All other recordings were processed 
using an in-house software package developed in Matlab (Mathworks). 
Mean values for miniature postsynaptic current parameters were calcu-
lated as a mean of means. Speciﬁ  cally, a mean value (e.g., mEPSC amp-
litude) was computed for all events recorded in a cell and averaged for 
subsequent comparison between WT and PrP-null animals. Raw values 
were used for calculating cumulative probability. In instances in which the 
total number of events was different between WT and PrP-null conditions 
(e.g., 450 mEPSCs in WT and 700 in knockout), we used SPSS software 
to randomly sample 450 events from the 700, and these were used for 
subsequent analysis. This was done in order not to bias the calculation of 
cumulative ensemble-type statistics. Cumulative probability plots were com-
pared, and signiﬁ  cant differences were established for P   <   0.05 using the 
Kolmogorov-Smirnov test. 
  For NMDA puff experiments, a second micromanipulator with a 
patch pipette was brought in the vicinity of the cell soma; position and dis-
tance were kept as constant as possible using video guidance with desig-
nated markings on the viewing monitor for cell center in relation to the puff 
electrode placement. NMDA was applied at a concentration of 100   μ  M 
(made in external solution) and a pressure of 8 psi; the electrode tip diam-
eters were similar to those used for the whole cell patch experiments. The 
three puff durations used (50, 100, and 500 ms) were computer controlled 
for timing and initiation using a DigiData 1322A interface (MDS Analyti-
cal Technologies) to deliver the transistor  –  transistor logic pulse. Analogous 
protocols were used for GABA and AMPA puff experiments. 
  Immunoﬂ  uorescence microscopy of neuronal cultures 
  Cells were grown on glass coverslips, brieﬂ  y rinsed with PBS, and ﬁ  xed for 
15 min with 4% PFA at room temperature. Coverslips were rinsed three 
  Brain slices 
  Adult male and female WT mice between P30 and P45 were used for all 
slice experiments. Mice were anaesthetized with halothane and quickly 
decapitated. The brain was dissected and maintained in ice-cold aCSF for 
    1 min. 250-  μ  m horizontal hippocampal slices were obtained at an angle 
of 12  °   in the frontal-occipital direction (Vibratome 1000; Vibratome, Inc.) 
while submerged in ice-cool oxygenated aCSF. The slices were immedi-
ately transferred to a holding chamber, where cool oxygenated aCSF was 
gradually warmed to 32  °  C at the end of the sectioning and maintained at 
that temperature for 2  –  5 h for subsequent electrophysiological recordings. 
All slices were allowed a minimum of 1 h of recovery before experimenta-
tion. Tissue samples used for all biochemical and/or protein biochemistry 
experiments consisted of the isolated whole intact hippocampus (from each 
hemisphere) as quickly dissected on an ice-cold surface with regular perfu-
sion of cold oxygenated aCSF. 
  Neuronal primary culture and transfection 
  Dissociated hippocampal neurons were prepared as previously described 
(  Khosravani et al., 2005  ). Electroporation was used to introduce exoge-
nous plasmid (either cDNA or siRNA) constructs into the cells; this was per-
formed after trituration, while cells were in suspension and before plating. 
3  –  5   μ  g of enhanced YFP was used as the transfection marker. The electro-
poration protocol consisted of the following: voltage of 100 V, square 
pulse duration of 100 ms, one pulse, and a 4-mm cuvette (X-Cell; Bio-Rad 
Laboratories). All data obtained from neuronal culture-based experiments 
were obtained from at least three separate culture rounds. 
  Molecular biology 
  Mouse   Prnp   cDNA (GenBank/EMBL/DDBJ accession no.   BC006703  ) was 
cloned into pCMV-SPORT6 (Open Biosystems); this construct was used for 
PrP reconstitution experiments. For siRNA experiments, we used mouse ret-
roviral short hairpin RNA (shRNAmir) with individual clones spanning dif-
ferent regions of the   mPrnp   sequence (clone ID RMM1766-98468689, 
RMM1766-96744825, and RMM1766-9336256) cloned in pSHAG-
MAGIC2 (Open Biosystems). All three siRNA constructs were cotransfected 
into neurons. For NR2D RNAi experiments, we used the following 
shRNAmir constructs: clone ID TRCN0000100210, TRCN0000100211, 
TRCN0000100212, TRCN0000100213, and TRCN0000100214. Each 
construct was tested independently in transfection experiments to evaluate 
knockdown efﬁ   ciency, and the 212 and 214 constructs were used for 
knockdown and produced identical results, which were pooled. To achieve 
maximum purity, plasmids were prepared using the endonuclease-free 
Maxiprep kit according to the manufacturer  ’  s instructions (QIAGEN). 
  RT-PCR analysis of NMDAR subunit and PrP expression 
  Total mRNA was isolated from adult (P30  –  45) or neonatal (P0  –  1) hippo-
campal homogenate using TRIZOL. The quality of RNA was analyzed by 
agarose gel electrophoresis and ethidium bromide staining by standard 
methods. The mRNA was reverse transcribed using Superscript III and 
oligo-dT primers. Approximately 5   μ  g of total RNA was used for each re-
verse transcription reaction. Afterward, the ﬁ  rst-strand synthesis RNA was 
digested by treatment with RNAse H. The single-stranded cDNA was stored 
at     20  °  C until it was used for PCR ampliﬁ  cation. These experiments were 
performed in a blinded manner and performed on tissues obtained from 
two or more independent pairs of WT and PrP-null animals. Synthetic oli-
godeoxynucleotides based on the four known mouse NR2 subunit se-
quences and mouse PrP were synthesized (University of Calgary DNA 
synthesis facility). For each receptor subtype, two different regions of 
mRNA sequence were selected: a region in the 5  ’   half and another close 
to the 3  ’   end region. Additionally, one primer set was designed for ampliﬁ  -
cation of     -actin. Primer sequences are shown in Table S1 (available at 
http://www.jcb.org/cgi/content/full/jcb.200711002/DC1), and repre-
sentative experimental results are shown in Fig. S4. 
  Electrophysiology 
  All slice and cultured cell recordings utilized a standard extracellular solu-
tion (aCSF) containing the following: 125 mM NaCl, 5 mM KCl, 1.25 mM 
NaH  2  PO  4  , 2 mM MgSO  4  , 1.5 mM CaCl  2  , 25 mM NaHCO  3  , and 10 mM 
    D      -  glucose, pH 7.4, when bubbled with 95% O  2   and 5% CO  2  . The osmolar-
ity was 310   ±   5 mosM. For recording seizurelike events, in a model of 
spontaneous recurrent seizures, the superfusing aCSF was switched to one 
that lacked MgSO  4  . All ﬁ  eld recordings were performed in the CA1 layer of 
the hippocampus. Evoked (orthodromic) ﬁ  eld responses were delivered using 
a bipolar stimulating electrode placed in the Schaffer collaterals. The stimulus 
was generated by a constant voltage stimulator (DS2A-MKII; DigiTimer) 563 PRION PROTEIN MODULATES NMDA CURRENTS   •   Khosravani et al.
  ELISA assays 
  Hippocampal neurons (DIV 14) were ﬁ  xed in 4% PFA followed by two 
5-min washes with PBS. Half of the cells were permeabilized with 0.1% 
Triton X-100 for 5 min followed by a 30-min incubation in blocking solution 
(PBS + 3% BSA). The expression of NR2D was measured using an anti-
body raised against a peptide mapping to the N terminus of the NR2D 
subunit (R-20; 1:200; Santa Cruz Biotechnology, Inc.) and an HRP-conjugated 
donkey anti  –  goat (1:1,000; Jackson ImmunoResearch Laboratories). 
SuperSignal ELISA femto maximum sensitivity substrate (Thermo Fisher Sci-
entiﬁ  c) was added, and luminescence was measured with a luminometer 
(Victor 2; PerkinElmer) as described previously (  Altier et al., 2006  ). The ra-
tio between signals obtained from nonpermeabilized (i.e., surface expres-
sion) and permeabilized neurons (i.e., total expression) was then calculated 
from 12 coverslips (six permeabilized and six nonpermeabilized) with WT 
and 10 coverslips with PrP-null neurons. 
  In vitro excitotoxicity assays 
  Primary hippocampal cultures between DIV 16 and 18 were used in 
NMDA excitotoxicity assays. Coverslips were transferred to a new 24-well 
dish with fresh medium. Cells were exposed to vehicle (control) or NMDA 
at varying concentrations (0.3, 0.6, and 1.0 mM) for 20 min. Coverslips 
were then transferred back to their originating wells and allowed to re-
cover for 24 h after exposure. Cells were exposed to trypan blue dye 
(0.4% stock diluted to 1:100) for 1 min. Coverslips were washed in 3  ×   
PBS and ﬁ  xed with 4% PFA. These coverslips were then stained with a 
TUNEL cell death detection kit (Chemicon), and the number of TUNEL-positive 
cells was counted for each NMDA concentration. Imaging was performed 
in PBS for trypan blue  –  stained cells and on mounted coverslips for TUNEL-
stained cells. For each imaging session, six randomly selected ﬁ  elds were 
imaged using conventional light microscopy (40  ×  ). Within each ﬁ  eld, the 
total number of cells was visualized by either differential interference con-
trast (for trypan blue) or via counterstaining with methyl green (for TUNEL). 
The number of trypan blue and TUNEL cells were counted during indepen-
dent imaging sessions. The number of positively stained cells (either trypan 
or TUNEL) was reported as a fraction of the total number of cells taken as 
a mean over the imaged ﬁ  elds. All in vitro excitotoxicity experiments were 
repeated using at least two independent culture rounds. 
  Lesion surgery and Fluoro-Jade staining 
  10  –  12-wk-old mice were anesthetized with ketamine/xylazine given at a 
dose of 85/15 mg/kg intraperitoneally and were mounted in a stereotaxic 
frame (Kopf Instruments). The mice received hippocampal injections of 1   μ  l 
of a solution containing 10 nmol NMDA in PBS with the following stereo-
taxic coordinates: 2.0 mm caudal to bregma, 2.0 mm lateral to midline, 
and 2.0 mm ventral from the bone surface. NMDA was injected over 5 min, 
and the needle was left in place for an additional 5 min to minimize the 
leakage. Animals were maintained according to Canadian Council on 
Animal Care guidelines, and this study was approved by the University of 
Calgary Animal Care Committee. 48 h after NMDA injection, mice were 
deeply anesthetized with ketamine/xylazine and transcardially perfused 
with PBS followed by 4% PFA in PBS. The brains were removed, placed 
in 4% PFA overnight at 4  °  C, and dehydrated in 20% sucrose/PBS for 1 d. 
The brain samples were frozen in optimal cutting temperature compound 
(Sakura Finetek) at     80   °  C. 25-  μ  m coronal sections were cut by cryostat, 
mounted on the slide glass, dried, and immersed in 100% ethanol followed 
by 70% ethanol. Sections were then treated with 0.06% potassium perman-
ganate for 15 min, rinsed by PBS, and immersed in Fluoro-Jade C (0.001% 
in 0.1% acetic acid; Histo-Chem, Inc.) for 30 min. After rinsing, sections 
were dried and mounted with xylene-based mounting media for analysis. 
  Statistics 
  Statistical analyses were performed using SigmaStat (SPSS, Inc). Unless 
stated otherwise, statistical signiﬁ  cance was evaluated using   t   tests for com-
paring two groups and one-way analysis of variance for comparison of 
multiple groups versus control using the Bonferroni posthoc test. Statistical 
signiﬁ  cance was reported for quantities with P   <   0.05 (single asterisk) and 
P   <   0.001 (double asterisks). 
  Spectral analysis of epileptiform discharges 
  Fourier-based analysis was used to characterize the cumulative power 
spectral amplitude for each discharge (Fig. S1). This was computed for 
ﬁ  ve frequency bands (0  –  500 Hz; 100-Hz increments for each bandwidth). 
The analysis was performed for 500 randomly selected discharges each 
from seizurelike events in WT (  n   = 18) and PrP-null (  n   = 21) slices. All cal-
culations were conducted using Matlab software. 
times with PBS and after blocking nonspeciﬁ  c binding with blocking buffer 
(3% BSA in PBS). They were incubated overnight at 4  °  C with the primary 
antibody in blocking buffer. Pre- and postsynaptic contacts were visualized 
by costaining with anti  –  synapsin-I (1:1,000; Chemicon) conjugated with 
AlexaFluor568 goat anti  –  rabbit IgG (1:1,000; Invitrogen) and anti-NR1 
(1:500; Synaptic Systems GmbH) conjugated with AlexaFluor488 goat 
anti  –  mouse IgG (1:1,000; Invitrogen). NR2D subunit distribution was de-
tected using a polyclonal antibody raised against a peptide mapping to 
the N terminus of the NR2D subunit, anti-NR2D (R-20; 1:200; Santa Cruz 
Biotechnology, Inc.), conjugated with either AlexaFluor488 or 568 donkey 
anti  –  goat IgG. For NR2D and PrP colocalization, NR2D (1:200; Santa 
Cruz Biotechnology, Inc.) and mouse monoclonal anti-PrP (1:200; Chemi-
con) antibodies were used and conjugated to AlexaFluor488 IgG and 
AlexaFluor546 IgG, respectively. Secondary antibodies were used at a 
1:1,000 dilution. After secondary staining, the coverslips were subjected 
to three washing cycles with PBS and were stored in PBS containing a drop 
of Vectashield antifade reagent (Vector Laboratories). All immunostaining 
of neuronal cultures was repeated on a minimum of two independent cul-
ture rounds for NR1 and greater than three for NR2D and PrP. 
  All epiﬂ   uorescence imaging was performed on an upright micro-
scope (Axioskop 2 FS; Carl Zeiss, Inc.) with infrared     differential interfer-
ence contrast and ﬂ  uorescence capability. Images were visualized through 
water immersion objectives (either Achroplan 40  ×   0.8 NA or Achroplan 
63  ×   0.95 NA; Carl Zeiss, Inc.). Epiﬂ  uorescence was visualized through 
dichroic mirrors with the following excitation/emission ﬁ  lter  properties: 
450  –  490/515  –  565 nm (green channel), 500  –  520/535  –  565 nm (yellow 
channel), and 530  –  585/long-pass 615 nm (red channel). Imaging was 
typically performed using unmounted coverslips in PBS. Images were ac-
quired using a CCD camera with on-chip signal integration (120N; Watec) 
and sampled by a high resolution video capture card. Confocal imaging 
was performed using a microscope (LSM510 Meta; Carl Zeiss, Inc.) with 
a 63  ×   1.4 NA oil immersion objective (Carl Zeiss, Inc.). The entire cell 
volume was imaged by a series of z-plane sections, resulting in z-stacks. 
Fluorescence was visualized via laser excitation and emission, with se-
quential activation detected using dichroic and ﬁ  lter optics with the following 
excitation/emission properties: 488/long pass 505 nm (for NR2D) and 
543/long pass 585 nm. 
  Coimmunoprecipitations and immunoblotting 
  The hippocampal region was quickly dissected under a microscope 
(SMZ645-660; Nikon) and used as a sample. Neonatal samples were col-
lected from P0  –  1 pups, whereas adult samples were obtained from P30  –  45 
mice. The tissue was homogenized by a Dounce homogenizer in cold 
lysis buffer (300 mM NaCl, 10 mM Tris-Cl, pH 8.0, and 0.5% Triton X-100 
plus protease inhibitor cocktail [Roche]). After incubating on ice for 1 h, the 
supernatant was collected. The homogenate was centrifuged at 10,000   g   
for 20 min at 4  °  C, supernatant was collected, and the protein concentra-
tion was determined using the Protein Assay kit (Bio-Rad Laboratories). 
Subsequently, 20  –  30   μ  g of protein was loaded per lane onto a 10% SDS 
polyacrylamide gel, and Western blot analysis was performed. The follow-
ing antibodies were used for the blots: anti-NR2D at 1:200 (Santa Cruz 
Biotechnology, Inc.), anti-NR2B at 1:500 (Calbiochem), and anti-PrP at 
1:200 (Santa Cruz Biotechnology, Inc.). After 2 h at room temperature, the 
membrane was washed three times in the PBS containing 0.5% Tween 200 
for 30 min and incubated for 1 h in HRP-conjugated second antibody 
(1:10,000). Antigen was detected using enhanced chemiluminescent HRP 
substrate (ECL; GE Healthcare). Immunoreactive bands were visualized af-
ter exposure of the membranes to Hyperﬁ  lm MP (GE Healthcare). 
  For immunoprecipitation, 70 mg of tissue was homogenized by 
Dounce homogenizer in 500   μ  l of cold lysis buffer with protease inhibitor. 
The sample was left on ice for 1 h and spun at 10,000   g   for 20 min at 4  °  C, 
and supernatant was collected. 100   μ  l of lysate was diluted to 500   μ  l with 
lysis buffer (5 mM Tris, pH 7.5, 300 mM NaCl, 0.5% Triton X-100, and a 
cocktail of protease inhibitor) and precleared by 25   μ  l of protein A/G Seph-
arose (GE Healthcare) for 30 min. The solution was spun at high speed, and 
supernatant was collected. 5   μ  g of antibody was then added to lysate and 
incubated at 4  °  C overnight. 50   μ  l of protein A/G Sepharose was then 
added to collect the immunoprecipitate. Samples were incubated 4  °  C for 
2 h and centrifuged at 800 rpm for 1 min, and supernatant was collected. 
The precipitate was washed three times with 1 ml of lysis buffer. 50   μ  l of 
2  ×   sample buffer was added to each sample and run on an SDS polyacryl-
amide gel. 20   μ  l of each sample was loaded onto the gel. Separated protein 
were transferred to nitrocellulose and probed with various antibodies. These 
experiments were performed in a blinded manner and using tissues obtained 
from a minimum of three independent pairs of WT and PrP-null animals. JCB • VOLUME 181 • NUMBER 3 • 2008  564
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